Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Long Term Debt Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual long term debt in 2023 was 2.4 Billion CNY , up 3.72% from previous year.
Innovent Biologics, Inc.'s latest quarterly long term debt in 2023 FY was 2.4 Billion CNY , up 3.72% from previous quarter.
Innovent Biologics, Inc. reported annual long term debt of 2.31 Billion CNY in 2022, up 9.69% from previous year.
Innovent Biologics, Inc. reported annual long term debt of 2.1 Billion CNY in 2021, up 125.53% from previous year.
Innovent Biologics, Inc. reported quarterly long term debt of 2.4 Billion CNY for 2023 Q4, down 0.0% from previous quarter.
Innovent Biologics, Inc. reported quarterly long term debt of 2.4 Billion CNY for 2023 FY, up 3.72% from previous quarter.

Annual Long Term Debt Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Long Term Debt of Innovent Biologics, Inc. (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	2.4 Billion CNY	3.72%
2022	2.31 Billion CNY	9.69%
2021	2.1 Billion CNY	125.53%
2020	935.41 Million CNY	12.36%
2019	832.53 Million CNY	6.46%
2018	782 Million CNY	54.85%
2017	505 Million CNY	1.0%
2016	500 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q2	2.97 Billion CNY	0.0%
2023 Q4	2.4 Billion CNY	0.0%
2023 FY	2.4 Billion CNY	3.72%
2023 Q3	2.4 Billion CNY	-19.33%
2023 Q1	2.97 Billion CNY	28.57%
2022 Q1	1.89 Billion CNY	-10.31%
2022 FY	2.31 Billion CNY	9.69%
2022 Q3	2.31 Billion CNY	22.3%
2022 Q2	1.89 Billion CNY	0.0%
2022 Q4	2.31 Billion CNY	0.0%
2021 Q3	2.1 Billion CNY	43.39%
2021 FY	2.1 Billion CNY	125.53%
2021 Q1	1.47 Billion CNY	57.29%
2021 Q2	1.47 Billion CNY	0.0%
2021 Q4	2.1 Billion CNY	0.0%
2020 Q1	809.4 Million CNY	-2.78%
2020 Q3	935.41 Million CNY	15.57%
2020 Q2	809.4 Million CNY	0.0%
2020 Q4	935.41 Million CNY	0.0%
2020 FY	935.41 Million CNY	12.36%
2019 FY	832.53 Million CNY	6.46%
2019 Q4	832.53 Million CNY	0.0%
2019 Q3	832.53 Million CNY	3.34%
2019 Q2	805.61 Million CNY	0.0%
2019 Q1	805.61 Million CNY	3.02%
2018 Q1	4.23 Billion CNY	739.03%
2018 Q3	782 Million CNY	13.83%
2018 FY	782 Million CNY	54.85%
2018 Q4	782 Million CNY	0.0%
2018 Q2	687 Million CNY	-83.79%
2017 Q3	3.55 Billion CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q4	505 Million CNY	-85.8%
2017 FY	505 Million CNY	1.0%
2016 FY	500 Million CNY	0.0%

Peer Long Term Debt Comparison of Innovent Biologics, Inc.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-7740.713%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	43.828%